Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Recover Investment Losses: Class Action Initiated Against Veritone, Inc. (VERI)

accessnewswire.com
VERI

Class Action Alert: Levi & Korsinsky Reminds Phreesia, Inc. (PHR) Investors of July 13, 2026 Deadline

accessnewswire.com
PHR

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

accessnewswire.com
GRAL

Class Action Alert: Levi & Korsinsky Reminds Commvault (CVLT) Investors of July 17, 2026 Deadline

accessnewswire.com
CVLT

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Badger Meter, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BMI

accessnewswire.com
BMI

Vertex Adds Chad Paulin as new AI Strategy Officer

prnewswire.com
VRTX

Class Action Alert: Levi & Korsinsky Reminds Embecta (EMBC) Investors of August 17, 2026 Deadline

accessnewswire.com
EMBC

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

accessnewswire.com
WGS

RBLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Notifies Roblox (RBLX) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026 Ready to Announce with Confidence?

newsfilecorp.com
RBLX

Samsung Bioepis anuncia dados preliminares positivos das Fases 1 e 3 para o SB27, um biossimilar proposto para o Keytruda (Pembrolizumabe)

businesswire.com
MRK
View all news →